NHS England has officially unveiled its comprehensive 10-Year Health Plan, setting out a detailed blueprint designed to reshape health provision across the country over the coming decade. The sweeping strategy outlines significant systemic changes intended to entirely transform care quality, accessibility, and outcomes across England by the year 2035. For people living with rare and complex conditions, the transition period represents a pivotal juncture. While the broad strokes of the strategy promise modernization, patient advocacy groups are closely examining how these high-level ambitions will translate into tangible improvements for specific patient populations.
The Tuberous Sclerosis Association (TSA) has thoroughly reviewed the extensive report to evaluate its direct relevance to the Tuberous Sclerosis Complex (TSC) community. TSC is a complex, multi-system genetic condition that causes benign tumors to grow in various organs, most frequently affecting the brain, kidneys, heart, skin, and lungs. It is frequently accompanied by neurological and psychological challenges known as TAND (TSC-Associated Neuropsychiatric Conditions). Because TSC impacts multiple organ systems simultaneously, patients often require coordinated, multidisciplinary care spanning various medical specialties throughout their lives. Consequently, any sweeping reform of the National Health Service carries profound implications for how individuals and families manage this lifelong condition.
More Integrated and Local Care
A foundational priority at the heart of the new 10-year strategy is a deliberate structural shift in how healthcare resources are deployed, moving away from centralized hospital dominance toward more decentralized, community-based settings. NHS England has branded this operational evolution as its “Neighbourhood Health Service.” The overarching aim of this transformation is to ensure that patients receive more personalized, accessible care within their own local communities rather than being forced to travel long distances to major hospitals for routine appointments, check-ups, and scans.
Under the proposed model, local health facilities delivering these community services will operate on an expanded schedule, remaining open for at least 12 hours a day, six days a week. NHS England envisions that this localized approach will foster a more preventative healthcare culture, enabling clinicians to identify health issues and emerging symptoms before they escalate into larger, more critical problems. Additionally, policymakers hope that streamlining services at the neighborhood level will significantly reduce waiting times and alleviate chronic congestion in acute hospital settings.
For the TSC community, this localized shift could alleviate a substantial portion of the logistical burden associated with managing a multi-system condition. Patients and their families would no longer need to constantly juggle numerous appointments spread across different hospitals or endure exhausting travel times simply to attend routine TSC-based check-ups and surveillance scans. Furthermore, a successful neighborhood health model should theoretically facilitate closer collaboration among different healthcare professionals working within the same locality, ensuring a more unified understanding of an individual’s comprehensive health needs rather than dealing with fragmented, disconnected medical teams.
A Greater Focus on the NHS App
Digital transformation forms another critical pillar of the newly released framework. The NHS App is slated to undergo substantial enhancements over the coming years, designed to give patients easier, more centralized management over appointments, repeat prescriptions, and broader health information. A core feature of this digital upgrade is providing individuals with secure, direct access to their own comprehensive medical records, thereby simplifying day-to-day communication with various healthcare providers across the system.
For individuals living with TSC, managing medical history can be an exceptionally daunting task. Because the condition affects multiple organ systems, patients frequently accumulate a vast array of health records scattered across different departments, hospitals, and clinical specialties. Tracking this dispersed medical history is often challenging not only for patients and their families but also for the doctors and nurses attempting to coordinate their care. Enhancing the NHS App to provide a unified, accessible repository of medical history could dramatically improve care continuity and clinical decision-making.
However, the practical implementation of this digital-first strategy raises important questions regarding accessibility and inclusivity. In particular, uncertainties remain regarding how the enhanced app will accommodate patients who rely heavily on family members or formal caregivers to manage their healthcare needs. Clear protocols must be established to determine whether caregivers will be granted appropriate, secure proxy access to view and manage medical records and communications on behalf of the vulnerable individuals they support.
Improved Access to Specialist Treatments
Innovation is heavily emphasized throughout the 10-Year Health Plan, with a particular focus on harnessing cutting-edge technologies such as genomics and artificial intelligence to personalize treatment pathways and predict individual health risks with greater accuracy. NHS England has set an ambitious target to position the health service as a global leader in genomics, aiming to introduce universal newborn genomic testing by the year 2030. Concurrently, artificial intelligence is framed as a clinician’s “trusted assistant,” intended to make clinical workflows more impactful, efficient, and streamlined.
While much remains to be determined regarding how these advanced technologies will be successfully deployed in everyday clinical practice, the overarching vision offers genuine hope for the rare disease community. Earlier genetic screening protocols could fundamentally change the trajectory of conditions like TSC by enabling clinicians to confirm a diagnosis in newborns far earlier than is currently possible. Earlier confirmation naturally leads to earlier, more proactive intervention and monitoring strategies.
For adults already living with TSC, the integration of advanced data analytics and artificial intelligence holds the potential to refine ongoing treatment regimens and symptom management. Advanced algorithms might eventually assist clinicians in recognizing subtle physiological patterns or disease progressions associated with TSC that are not easily identifiable under current diagnostic frameworks. Nevertheless, the TSC community emphasizes that much more concrete detail is required regarding how artificial intelligence will be safely regulated, validated, and integrated into routine clinical pathways.
A Stronger Focus on Prevention and Early Intervention
At present, the operational reality of NHS England remains predominantly reactive—focusing heavily on treating acute medical crises after they have already manifested, such as surgically intervening on a TSC-related kidney tumor only after it has grown large enough to cause severe clinical complications. The 10-Year Health Plan explicitly articulates a desire to transition away from this reactive posture toward a proactive system anchored in prevention, early intervention, and predictive healthcare models.
Achieving this shift will require increased reliance on continuous monitoring technology, including wearable devices and remote tracking tools. By continuously observing physiological changes, NHS England hopes to catch and address emerging health issues well before they escalate into major medical emergencies. For the TSC community, this proactive philosophy aligns closely with the clinical reality of managing a condition characterized by progressive, age-related manifestations.
It is well established within clinical neurology and nephrology that the physical impact of TSC can evolve significantly over time. For instance, new TSC-related growths, such as angiomyolipomas or cysts, can develop in the kidneys of individuals who have never previously experienced renal complications. If the NHS can successfully implement systems capable of detecting subtle bodily changes rapidly and reliably, these renal growths could be identified while they are still in their infancy. Spotting these developments early could profoundly enhance the efficacy of medical therapies designed to halt or reduce tumor progression before irreversible organ damage occurs.
Better Mental Health Support
Mental health care receives a significant financial and structural commitment within the 10-Year Health Plan, reflecting a growing recognition of psychological well-being as a core component of overall health. The strategy outlines substantial investments intended to expand dedicated mental health emergency services, provide round-the-clock virtual access to qualified therapists for individuals experiencing mild to moderate psychological distress, and streamline pathways for self-referral. Additionally, the plan calls for an expansion of specialized mental health support teams within schools to ensure that children and young adults receive early psychological intervention. NHS England anticipates that these measures will drastically reduce waiting times for specialist mental healthcare while simultaneously easing the severe operational strain currently placed on hospital Accident and Emergency departments.
For the TSC community, these proposed enhancements are particularly pertinent. It is now widely recognized that TSC-Associated Neuropsychiatric Conditions (TAND)—which encompass a wide spectrum of behavioral, psychiatric, intellectual, and psychosocial challenges—represent a profound daily challenge for a vast number of individuals and families living with the condition. Despite the high prevalence and profound impact of TAND, accessing timely, specialist psychological and psychiatric support through the public health system has historically proven extremely difficult. The implementation of expanded mental health services and virtual therapy access offers a hopeful pathway toward more equitable, timely, and impactful mental health support for people affected by TSC across England.
The TSA’s View on the 10-Year Health Plan
The Tuberous Sclerosis Association maintains that the current health system in England falls short of providing the comprehensive, coordinated support that the TSC community requires. Consequently, the ambitious scope of the 10-Year Health Plan represents a substantial opportunity to improve healthcare access, management, and long-term outcomes for individuals and families navigating life with TSC. In particular, the strategic emphasis on integrated, localized care—free from the traditional information silos where different clinicians lack access to complete patient records—has the potential to create a positive domino effect of improved lifelong health outcomes.
However, the charity strikes a cautious note regarding the transition from strategic vision to actual delivery. Writing comprehensive plans on paper is a straightforward administrative exercise; the true test lies in transforming these ambitious concepts into a tangible reality for patients on the ground. The TSA warmly welcomes the overarching vision outlined in the strategy but eagerly anticipates concrete proof that the commitments will be fully realized rather than progressively diluted over time.
Furthermore, the charity has voiced significant concern regarding the plan’s notable lack of emphasis on rare diseases as a distinct category. Within the entirety of the expansive strategy document, the word "rare" appears merely eight times—an omission that the organization views as entirely unacceptable given the millions of individuals in the UK affected by rare and complex conditions. As these long-term commitments are operationalized, the TSC charity has pledged to utilize every available resource to hold NHS England strictly accountable to the promises and hopes laid out in the agreed strategy.
